Tag: #Global Trends

Moderna has resolved a protracted legal battle by agreeing to a $950 million upfront settlement with Genevant and Arbutus Biopharma.... Read more

German conglomerate Bayer has outlined its 2026 business outlook, characterizing it as the final year of a "resilience phase" before... Read more

A comprehensive study recently released by the non-profit organization Consumer Reports has highlighted the presence of arsenic, lead, and per-... Read more

On March 2, 2026, Novo Nordisk announced a 432 million Euro investment (approximately 3.2 billion DKK) in its Monksland facility... Read more

A strategic alliance combining artificial intelligence with advanced biopharmaceutical manufacturing has been formed between WuXi XDC and Earendil Labs. The... Read more

Atrium Therapeutics Inc. has debuted as a newly independent, publicly traded biotechnology firm dedicated to developing innovative RNA medicines. The... Read more

The European Medicines Agency’s CHMP has issued a positive opinion for the approval of Olumiant (baricitinib) for adolescents aged 12... Read more

The stock market recently witnessed a significant sell-off of UniQure (a Dutch biotech firm), wiping out nearly $500 million in... Read more

The Committee for Medicinal Products for Human Use (CHMP) has issued landmark recommendations, paving the way for advanced medicines and... Read more